Spectroscopy Solutions for Pharmaceuticals

Technical notes | 2016 | Agilent TechnologiesInstrumentation
UV–VIS spectrophotometry
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Significance of the Topic


UV-Vis spectroscopy plays a key role in pharmaceutical research, QA/QC and clinical chemistry. Adherence to USP<857> ensures reliable performance through design qualification, lifecycle management and periodic verification of instrument accuracy, precision, stray light and resolution.

Objectives and Study Overview


This white paper reviews the revised USP<857> performance criteria for UV-Vis instruments and demonstrates how the Agilent Cary 60 UV-Vis spectrophotometer with Cary WinUV software automates and simplifies compliance testing.

Methodology and Used Instrumentation


The study follows USP<857> protocols for operational qualification across four performance areas:
  • Wavelength control: accuracy and precision tests using holmium perchlorate and didymium standards
  • Absorbance control: photometric accuracy and precision tests with potassium dichromate and NIST filters
  • Stray light assessment: %T measurements at specified wavelengths using defined test solutions
  • Resolution evaluation: toluene in hexane spectrum analysis at 269 and 266 nm

Instrumentation:
  • Agilent Cary 60 UV-Vis spectrophotometer with Xenon flash lamp
  • Agilent Cary WinUV software Validate application on Windows 10

Main Results and Discussion


The Cary 60 UV-Vis consistently met USP<857> tolerances:
  • Wavelength accuracy within ±1 nm (200–400 nm) and ±2 nm (400–700 nm); precision SD < 0.5 nm
  • Photometric accuracy for UV (<1 Abs ±0.01; >1 Abs ±1%) and visible ranges with precision SD within defined limits
  • Stray light below prescribed transmission thresholds at 198, 220, 320 and 370 nm
  • Resolution ratio at 269/266 nm in line with requirements

The Cary WinUV Validate application automates data acquisition, tolerance checks and report generation, reducing manual effort and error risk.

Contributions and Practical Applications


Routine automated OQ testing enhances laboratory efficiency and data integrity. The integration of preconfigured methods and electronic records supports regulatory compliance and streamlines maintenance and troubleshooting.

Future Trends and Potential Applications


Advances may include cloud integration for remote monitoring, AI-driven anomaly detection, portable UV-Vis devices for field QC, expanded CRM libraries and enhanced software modules for seamless LIMS interaction.

Conclusion


The Agilent Cary 60 UV-Vis with Cary WinUV software offers a comprehensive, automated solution for meeting USP<857> performance requirements, ensuring accurate, precise and reliable UV-Vis measurements in pharmaceutical settings.

References


  • Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma, Agilent Technologies White Paper, Publication 5991-7268EN (2016).

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)
Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24
USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition
UV/Vis Pharmacopeia Performance Verification on Lunatic & Stunner